Arecor Therapeutics PLC(DE:6UI)
€0.810.00 (0.00%)
DE:6UI
Arecor Therapeutics PLC financials statements
€0.81
At close:0.00 (0.00%)
Arecor Therapeutics PLC (6UI) Ratios
0 Followers
Arecor Therapeutics PLC Ratios
DE:6UI's free cash flow for Q2 2026 was £-3.33M. For the 2026 fiscal year, DE:6UI's free cash flow was decreased by £-25.00K and operating cash flow was £-3.30M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.35 | 2.53 | 2.17 | 4.69 | 9.05 |
| Quick Ratio | 4.35 | 2.38 | 2.02 | 4.38 | 9.05 |
| Cash Ratio | 1.86 | 0.99 | 0.99 | 1.28 | 8.08 |
| Solvency Ratio | 0.53 | -2.90 | -1.38 | -2.07 | -2.53 |
| Operating Cash Flow Ratio | -1.42 | -2.81 | -1.13 | -2.89 | -2.40 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -75.66 | -49.50 | -53.37 | -43.25 |
| Net Current Asset Value | £ 5.35M | £ 4.86M | £ 5.32M | £ 13.17M | £ 18.14M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.03 | 0.02 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.02 | 0.04 | 0.04 | 0.02 | 0.01 |
| Debt-to-Capital Ratio | 0.01 | 0.04 | 0.03 | 0.02 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.26 | 1.63 | 1.61 | 1.25 | 1.13 |
| Debt Service Coverage Ratio | -410.27 | -68.31 | -60.47 | -39.37 | -8.67 |
| Interest Coverage Ratio | -424.18 | -486.23 | -611.67 | -555.24 | -11.79 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.01 | 0.01 | 0.01 | 0.03 |
| Net Debt to EBITDA | 0.65 | 0.30 | 0.57 | 0.44 | 2.89 |
| Profitability Margins | |||||
| Gross Profit Margin | 61.32% | 30.54% | 100.00% | 100.00% | 100.00% |
| EBIT Margin | -272.23% | -209.70% | -194.31% | -432.92% | -555.96% |
| EBITDA Margin | -259.68% | -200.87% | -183.47% | -418.73% | -541.19% |
| Operating Profit Margin | -272.23% | -211.70% | -200.63% | -485.23% | -516.15% |
| Pretax Profit Margin | 57.99% | -210.13% | -194.64% | -438.70% | -599.74% |
| Net Profit Margin | 38.74% | -202.57% | -187.05% | -385.35% | -532.73% |
| Continuous Operations Profit Margin | 54.38% | -202.57% | -187.05% | -385.35% | -532.73% |
| Net Income Per EBT | 66.80% | 96.40% | 96.10% | 87.84% | 88.83% |
| EBT Per EBIT | -21.30% | 99.26% | 97.01% | 90.41% | 116.20% |
| Return on Assets (ROA) | 8.20% | -117.36% | -55.63% | -42.55% | -29.49% |
| Return on Equity (ROE) | 10.29% | -191.36% | -89.79% | -53.05% | -33.26% |
| Return on Capital Employed (ROCE) | -71.88% | -195.70% | -89.71% | -64.64% | -32.04% |
| Return on Invested Capital (ROIC) | -66.42% | -180.66% | -84.27% | -55.54% | -28.08% |
| Return on Tangible Assets | 8.21% | -117.80% | -70.81% | -50.43% | -29.53% |
| Earnings Yield | 2.18% | -41.65% | -15.31% | -13.33% | -6.70% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.97 | 1.76 | 1.60 | 3.62 | 1.46 |
| Payables Turnover | 0.47 | 4.19 | 1.48 | 0.20 | 0.00 |
| Inventory Turnover | 0.00 | 7.34 | 4.31 | 0.30 | 0.00 |
| Fixed Asset Turnover | 5.75 | 12.63 | 5.48 | 2.87 | 3.53 |
| Asset Turnover | 0.21 | 0.58 | 0.30 | 0.11 | 0.06 |
| Working Capital Turnover Ratio | 0.33 | 0.92 | 0.46 | 0.15 | 0.11 |
| Cash Conversion Cycle | -594.15 | 170.17 | 66.69 | -517.82 | 250.58 |
| Days of Sales Outstanding | 184.84 | 207.60 | 228.75 | 100.86 | 250.58 |
| Days of Inventory Outstanding | 0.00 | 49.71 | 84.71 | 1210.60 | 0.00 |
| Days of Payables Outstanding | 779.00 | 87.14 | 246.78 | 1829.28 | 0.00 |
| Operating Cycle | 184.84 | 257.31 | 313.47 | 1311.46 | 250.58 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.06 | -0.27 | -0.19 | -0.37 | -0.24 |
| Free Cash Flow Per Share | -0.06 | -0.27 | -0.20 | -0.38 | -0.24 |
| Dividend Paid and CapEx Coverage Ratio | -23.13 | -398.04 | -38.68 | -31.25 | -78.99 |
| Capital Expenditure Coverage Ratio | -23.13 | -398.04 | -38.68 | -31.25 | -78.99 |
| Operating Cash Flow Coverage Ratio | -23.37 | -39.46 | -17.28 | -37.43 | -23.59 |
| Operating Cash Flow to Sales Ratio | -1.34 | -1.81 | -1.28 | -4.49 | -4.71 |
| Free Cash Flow Yield | -7.86% | -37.34% | -10.72% | -16.02% | -5.99% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 45.74 | -2.40 | -6.53 | -7.50 | -14.93 |
| Price-to-Sales (P/S) Ratio | 17.73 | 4.86 | 12.22 | 28.90 | 79.56 |
| Price-to-Book (P/B) Ratio | 4.71 | 4.59 | 5.87 | 3.98 | 4.97 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -12.72 | -2.68 | -9.33 | -6.24 | -16.69 |
| Price-to-Operating Cash Flow Ratio | -13.27 | -2.68 | -9.57 | -6.44 | -16.91 |
| Price-to-Earnings Growth (PEG) Ratio | -0.43 | -0.22 | 0.52 | -0.40 | -0.09 |
| Enterprise Value Multiple | -6.18 | -2.13 | -6.09 | -6.46 | -11.82 |
| Enterprise Value | 27.49M | 21.57M | 51.13M | 64.97M | 74.05M |
| EV to EBITDA | -6.18 | -2.13 | -6.09 | -6.46 | -11.82 |
| EV to Sales | 16.04 | 4.27 | 11.18 | 27.04 | 63.95 |
| EV to Free Cash Flow | -11.51 | -2.35 | -8.53 | -5.84 | -13.42 |
| EV to Operating Cash Flow | -12.00 | -2.36 | -8.75 | -6.03 | -13.59 |
| Tangible Book Value Per Share | 0.17 | 0.16 | 0.20 | 0.49 | 0.80 |
| Shareholders’ Equity Per Share | 0.17 | 0.16 | 0.31 | 0.60 | 0.81 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.06 | 0.04 | 0.04 | 0.12 | 0.11 |
| Revenue Per Share | 0.05 | 0.15 | 0.15 | 0.08 | 0.05 |
| Net Income Per Share | 0.02 | -0.31 | -0.28 | -0.32 | -0.27 |
| Tax Burden | 0.67 | 0.96 | 0.96 | 0.88 | 0.89 |
| Interest Burden | -0.21 | 1.00 | 1.00 | 1.01 | 1.08 |
| Research & Development to Revenue | 1.57 | 0.60 | 1.31 | 3.58 | 4.65 |
| SG&A to Revenue | 1.85 | 1.22 | 1.95 | 2.31 | 2.06 |
| Stock-Based Compensation to Revenue | 0.19 | 0.03 | 0.14 | 0.21 | 0.42 |
| Income Quality | -3.45 | 0.86 | 0.68 | 1.02 | 0.78 |
Currency in GBP
